BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 11743585)

  • 1. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection.
    Kelly JM; Darcy PK; Markby JL; Godfrey DI; Takeda K; Yagita H; Smyth MJ
    Nat Immunol; 2002 Jan; 3(1):83-90. PubMed ID: 11743585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perforin dependence of natural killer cell-mediated tumor control in vivo.
    van den Broek MF; Kägi D; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1995 Dec; 25(12):3514-6. PubMed ID: 8566046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin.
    Hayakawa Y; Kelly JM; Westwood JA; Darcy PK; Diefenbach A; Raulet D; Smyth MJ
    J Immunol; 2002 Nov; 169(10):5377-81. PubMed ID: 12421908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK cells promote peritoneal xenograft rejection through an IFN-gamma-dependent mechanism.
    Lin ML; Zhan Y; Nutt SL; Brady J; Wojtasiak M; Brooks AG; Lew AM
    Xenotransplantation; 2006 Nov; 13(6):536-46. PubMed ID: 17059581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells.
    Denyer MS; Wileman TE; Stirling CM; Zuber B; Takamatsu HH
    Vet Immunol Immunopathol; 2006 Apr; 110(3-4):279-92. PubMed ID: 16325923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor rejection induced by CD70-mediated quantitative and qualitative effects on effector CD8+ T cell formation.
    Arens R; Schepers K; Nolte MA; van Oosterwijk MF; van Lier RA; Schumacher TN; van Oers MH
    J Exp Med; 2004 Jun; 199(11):1595-605. PubMed ID: 15184507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK cells promote islet allograft tolerance via a perforin-dependent mechanism.
    Beilke JN; Kuhl NR; Van Kaer L; Gill RG
    Nat Med; 2005 Oct; 11(10):1059-65. PubMed ID: 16155578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perforin is a major contributor to NK cell control of tumor metastasis.
    Smyth MJ; Thia KY; Cretney E; Kelly JM; Snook MB; Forbes CA; Scalzo AA
    J Immunol; 1999 Jun; 162(11):6658-62. PubMed ID: 10352283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
    Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Yamaguchi N; Yagita H; Okumura K
    Cell Immunol; 2001 Dec; 214(2):194-200. PubMed ID: 12088418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.
    Lee SH; Bar-Haim E; Machlenkin A; Goldberger O; Volovitz I; Vadai E; Tzehoval E; Eisenbach L
    Cancer Gene Ther; 2004 Mar; 11(3):237-48. PubMed ID: 14739939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells.
    Street SE; Hayakawa Y; Zhan Y; Lew AM; MacGregor D; Jamieson AM; Diefenbach A; Yagita H; Godfrey DI; Smyth MJ
    J Exp Med; 2004 Mar; 199(6):879-84. PubMed ID: 15007091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of perforin-independent NK cell-mediated cytotoxicity.
    Wallin RP; Screpanti V; Michaëlsson J; Grandien A; Ljunggren HG
    Eur J Immunol; 2003 Oct; 33(10):2727-35. PubMed ID: 14515256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic control of perforin gene expression. Functional evidence for two separate control regions.
    Lichtenheld MG; Podack ER; Levy RB
    J Immunol; 1995 Mar; 154(5):2153-63. PubMed ID: 7868890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for IFN-gamma in primary and secondary immunity generated by NK cell-sensitive tumor-expressing CD80 in vivo.
    Kelly JM; Takeda K; Darcy PK; Yagita H; Smyth MJ
    J Immunol; 2002 May; 168(9):4472-9. PubMed ID: 11970991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma.
    Wischhusen J; Jung G; Radovanovic I; Beier C; Steinbach JP; Rimner A; Huang H; Schulz JB; Ohgaki H; Aguzzi A; Rammensee HG; Weller M
    Cancer Res; 2002 May; 62(9):2592-9. PubMed ID: 11980654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells.
    Dao T; Mehal WZ; Crispe IN
    J Immunol; 1998 Sep; 161(5):2217-22. PubMed ID: 9725214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.
    Mortara L; Castellani P; Meazza R; Tosi G; De Lerma Barbaro A; Procopio FA; Comes A; Zardi L; Ferrini S; Accolla RS
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3435-43. PubMed ID: 16740768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response.
    Cavallo F; Martin-Fontecha A; Bellone M; Heltai S; Gatti E; Tornaghi P; Freschi M; Forni G; Dellabona P; Casorati G
    Eur J Immunol; 1995 May; 25(5):1154-62. PubMed ID: 7539748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexpression of CD40L and CD70 by semiallogenic tumor cells induces anti-tumor immunity.
    Cormary C; Hiver E; Mariamé B; Favre G; Tilkin-Mariamé AF
    Cancer Gene Ther; 2005 Dec; 12(12):963-72. PubMed ID: 15956983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.